Full Press Release Details
CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will participate at the following upcoming healthcare conferences in March:
Tuesday, March 13, 2018
Barclays Capital Global Healthcare Conference
Who: John Leonard, M.D., Chief Executive Officer and President
Location: Miami, Florida
Presentation Time: 3:50pm EST
Tuesday, March 20, 2018
Morgan Stanley Healthcare Corporate Access Day
Who: Tom Barnes, Ph.D., Senior Vice President, Innovative Sciences
Location: Boston, Massachusetts
One on one meetings only
Wednesday, March 21, 2018
Oppenheimer & Co. 28th Annual Healthcare Conference
Who: Tom Barnes, Ph.D., Senior Vice President, Innovative Sciences
Location: New York, New York
Presentation Time: 1:35pm EST
A live webcast of Intellia’s presentations will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for 14 days following each conference.
About Intellia Therapeutics
Vice President, Investor Relations
Jennifer Mound Smoter